What is SplashBIO™? 

SplashBIO™ is a new scalable biomarker platform for clinical trials for early biomarker, genetic, and cognitive testing. This innovation uses biomarker tests to accelerate enrollment, save money, and reduce screen failure rates.

Meet with us at AAIC & learn how SplashBIO™ can help improve your trial's efficiency!

Or come see us at booth number: 523

Watch the video for more on SplashBIO™

Select an available date and time to chat with us at

Alzheimer’s Association International Conference

on July 27-31, 2025 in Toronto, Canada.